Could a Personalized Strategy Using Accelerated Partial Breast Irradiation be an Advantage for Elderly Patients? A Systematic Review of the Literature and Multidisciplinary Opinion.
Luca TagliaferriValentina LancellottaGiuseppe CollocaFabio MarazziValeria MasielloGiorgia GarganeseGyörgy KovácsVincenzo ValentiniMaria Antonietta GambacortaPublished in: Journal of oncology (2020)
Accelerated partial breast irradiation (APBI) results in a safe and effective substitute for the adjuvant external beam radiotherapy in selected elderly early-stage breast cancer patients. Based on the relatively low toxicity, APBI should be advised in selected patients with life expectancies larger than 5-10 years.